| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
|
Hahn, Andrew W.
|
|
2019
|
3 |
1 |
p. 7-13
|
article
|
| 2 |
Clinical Trials Corner
|
Parikh, Mamta
|
|
2019
|
3 |
1 |
p. 79-80
|
article
|
| 3 |
Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review
|
Achkar, Tala
|
|
2019
|
3 |
1 |
p. 31-40
|
article
|
| 4 |
Radiation Therapy for Renal Cell Carcinoma
|
Choi, Rachel
|
|
2019
|
3 |
1 |
p. 1-6
|
article
|
| 5 |
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib – Results of NCI/CTEP Protocol 9048
|
Semrad, Thomas J
|
|
2019
|
3 |
1 |
p. 51-61
|
article
|
| 6 |
Real-World Outcome of 173 Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC) Cases: The Experience of the Center Group for Genitourinary Tumors
|
Martín, Almudena
|
|
2019
|
3 |
1 |
p. 41-50
|
article
|
| 7 |
Stereotactic Body Radiation Therapy for Renal Cell Carcinoma with Inferior Vena Cava Thrombus – Initial Experience Report and Literature Review
|
Freifeld, Yuval
|
|
2019
|
3 |
1 |
p. 71-77
|
article
|
| 8 |
Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
|
Bergerot, Paulo Gustavo
|
|
2019
|
3 |
1 |
p. 63-70
|
article
|
| 9 |
The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
|
Hoerner, Christian R.
|
|
2019
|
3 |
1 |
p. 15-29
|
article
|
Journal description